Skip to content
Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article Numinus Announces Listing of Warrants

Numinus Announces Listing of Warrants

  • Post published:January 22, 2021
  • Post category:Press Release
Read more about the article Mind Cure Health Inc. Announces $10 Million Bought Deal Public Offering

Mind Cure Health Inc. Announces $10 Million Bought Deal Public Offering

  • Post published:January 21, 2021
  • Post category:Press Release
Read more about the article Mydecine Innovations Group Files Preliminary Prospectus in Connection with Bought Deal Offering of Units

Mydecine Innovations Group Files Preliminary Prospectus in Connection with Bought Deal Offering of Units

  • Post published:January 21, 2021
  • Post category:Press Release
Read more about the article North American Psychedelics Index Published: Which Companies Will Be in the First Psychedelic ETF?

North American Psychedelics Index Published: Which Companies Will Be in the First Psychedelic ETF?

  • Post published:January 21, 2021
  • Post category:Analysis/News
Read more about the article Psyched Wellness Announces C$3M Bought Deal Private Placement Led by Canaccord Genuity

Psyched Wellness Announces C$3M Bought Deal Private Placement Led by Canaccord Genuity

  • Post published:January 21, 2021
  • Post category:Press Release
Read more about the article MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD

MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD

  • Post published:January 20, 2021
  • Post category:Press Release
Read more about the article Tryp Therapeutics Invited to Present at “Investing in Psychedelics” Conference

Tryp Therapeutics Invited to Present at “Investing in Psychedelics” Conference

  • Post published:January 19, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Announces New OTCQB Ticker: PSYCF

Psyched Wellness Announces New OTCQB Ticker: PSYCF

  • Post published:January 19, 2021
  • Post category:Press Release
Read more about the article BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada

BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada

  • Post published:January 19, 2021
  • Post category:Press Release
Read more about the article NeonMind Lists on the Frankfurt Stock Exchange

NeonMind Lists on the Frankfurt Stock Exchange

  • Post published:January 19, 2021
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2026, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More